Predicting T Cell Quality During Manufacturing Through an Artificial Intelligence-based Integrative Multi-Omics Analytical Platform
Preprint
Abstract
Large-scale, reproducible manufacturing of therapeutic cells with consistently high quality is vital for translation to clinically effective and widely accessible cell therapies. However, the biological and logistical complexity of manufacturing a living product, including challenges associated with their inherent variability and uncertainties of process parameters, currently make it difficult to achieve predictable cell-product quality. Using a degradable microscaffold-based T cell process as an example, we developed an Artificial Intelligence (AI)-driven experimental-computational platform to identify a set of critical process parameters (CPP) and critical quality attributes (CQA) from heterogeneous, high dimensional, time-dependent multi-omics data, measurable during early stages of manufacturing and predictive of end-of-manufacturing product quality. Sequential, Design-of-Experiment (DOE)-based studies, coupled with an agnostic machine-learning framework, were used to extract feature combinations from media assessment that were highly predictive of total live CD4 + and CD8 + naïve and central memory (CD63L + CCR7 + ) T cells and their ratio in the end-product. This computational workflow could be broadly applied to any cell therapy and provide a roadmap for discovering CQAs and CPPs in cell manufacturing.Keywords
All Related Versions
- Published version: Bioengineering & Translational Medicine, 7 (2), e10282.
This publication has 37 references indexed in Scilit:
- Posttranscriptional Control of T Cell Effector Function by Aerobic GlycolysisCell, 2013
- Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species SignalingImmunity, 2013
- Metabolic checkpoints in activated T cellsNature Immunology, 2012
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory DevelopmentImmunity, 2012
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- Stimulating IL-13 Receptors on T cells: A New Pathway for Tolerance Induction in Diabetes?Diabetes, 2011
- Probabilistic Quotient Normalization as Robust Method to Account for Dilution of Complex Biological Mixtures. Application in 1H NMR MetabonomicsAnalytical Chemistry, 2006
- Probing Latent Biomarker Signatures and in Vivo Pathway Activity in Experimental Disease States via Statistical Total Correlation Spectroscopy (STOCSY) of Biofluids: Application to HgCl2ToxicityJournal of Proteome Research, 2006
- Reverse signalling of membrane‐integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cellsImmunology, 2005
- On the Role of sIL‐2R Measurements in Rheumatoid Arthritis and CancersMediators of Inflammation, 2005